Asset Publisher

9 October 202016:39

Comment by Press Secretary of the Embassy of the Russian Federation in Ireland on the world’s first vaccine Sputnik V

  • en-GB1 ru-RU1

Sir,

I would like to follow up briefly on the article by Maresa Fagan “Hopes for Covid-19 vaccine but no certainty (“The Irish Examiner”, October 6, 2020).

Unfortunately, there is no mention in the piece about the world’s first vaccine Sputnik V developed by the Gamaleya National Research Center of Epidemiology situated in Moscow, Russia. The 3rd phase of its clinical trials involving 40 000 people has been under way since early September. The scientific publication about Phases I and II of Sputnik V clinic trials in the reputable journal The Lancet clearly proves the high safety and efficacy of the Russian vaccine while other foreign companies, developing Covid-19 vaccines, have yet to confirm the absence of risks for human health. Yet, another Russian vaccine EpiVacCorona by the Vector Research Center is to be registered by October 15.

Quite clear, the full picture of global fight against the coronavirus pandemic, described in your article, would be incomplete without mentioning the Russian vaccines.

Kind regards,

Victoria Loginova,

Press Secretary

of the Embassy of the Russian Federation in Ireland

184-186, Orwell Road, Rathgar, Dublin 14

 

Link to the article  -  https://www.irishexaminer.com/news/arid-40059800.html

Additional materials

Photos

Calendar

x
x

Archive

Advanced settings